View Past Agendas: 2014 | 2013 | 2012 |2011 |2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2015 Agenda

Bookmark and Share

The agenda for Convergence 2015 will be posted here once available. Please send speaker or topic suggestions to our program chair. Request an invitation.

Speakers this year will include:

  • Glenn Batchelder, Founder and Board Member, Civitas Therapeutics
  • Rick Batycky PhD, CSO, Acorda Therapeutics, Inc. and Founder and 
    former CSO, Civitas Therapeutics
  • Bruce Booth D.Phil, Partner, Atlas Venture
  • Doug Cole MD, General Partner, Flagship Partners
  • Brian Gallagher PhD, Partner, SR One
  • Peter Hecht PhD, CEO, Ironwood Pharmaceuticals
  • Tom Hughes PhD, President and CEO, Zafgen Inc.
  • Ken Kaitin PhD, Professor and Director, Tufts Center for the Study of Drug Development
  • Dan Lynch, Chairman, bluebird bio
  • Stelios Papadapolous PhD, Chairman, Biogen Idec, Exelixis, Regulus Therapeutics
  • Robert Plenge MD, PhD, Vice President, Merck Research Labs
  • Anna Protopapas, President, Millennium: The Takeda Oncology Company
  • David Schenkein MD, CEO, Agios Pharmaceuticals
  • Nancy Simonian MD, CEO, Syros Pharmaceuticals
  • Robyn Smith, CEO, ORIG3N